DBV Technologies SA (DBVT)
0.469
-0.02
(-3.91%)
USD |
NASDAQ |
Nov 22, 16:00
0.4662
0.00 (0.00%)
After-Hours: 20:00
DBV Technologies Free Cash Flow: -108.72M for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | -108.72M |
| June 30, 2024 | -105.49M |
| March 31, 2024 | -95.40M |
| December 31, 2023 | -80.33M |
| September 30, 2023 | -90.19M |
| June 30, 2023 | -90.99M |
| March 31, 2023 | -75.76M |
| December 31, 2022 | -56.42M |
| Date | Value |
|---|---|
| September 30, 2022 | -52.22M |
| June 30, 2022 | -54.75M |
| March 31, 2022 | -74.39M |
| December 31, 2021 | -109.16M |
| September 30, 2021 | -123.59M |
| June 30, 2021 | -143.65M |
| March 31, 2021 | -154.20M |
| December 31, 2020 | -168.42M |
Free Cash Flow Range, Past 5 Years
-168.42M
Minimum
Dec 2020
-52.22M
Maximum
Sep 2022
-98.98M
Average
-93.20M
Median
Free Cash Flow Benchmarks
| Edap TMS SA | -24.95M |
| Genfit SA | -- |
| Cellectis SA | 60.38M |
| Adaptimmune Therapeutics PLC | -56.05M |
| Akari Therapeutics PLC | -14.84M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -22.46M |
| Cash from Investing (Quarterly) | -0.109M |
| Cash from Financing (Quarterly) | 0.007M |
| Free Cash Flow Per Share (Quarterly) | -0.2376 |
| Free Cash Flow Yield | -241.1% |